Spots Global Cancer Trial Database for hiv
Every month we try and update this database with for hiv cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Pilot Study of Liposomal Doxorubicin Combined With Bevacizumab Followed by Bevacizumab Monotherapy in Adults With Advanced Kaposi s Sarcoma | NCT00923936 | Sarcoma, Kaposi | Liposomal Doxor... Bevacizumab | 18 Years - 99 Years | National Institutes of Health Clinical Center (CC) | |
| Analysis of Markers in the Blood Correlated With Neuropathic Pain | NCT02208206 | Neuropathy | 18 Years - | Charite University, Berlin, Germany | ||
| Potlako: A Programmatic Intervention to Improve Access to Timely Oncology Care | NCT02752061 | Neoplasms HIV Healthcare Disp... | Potlako interve... | 18 Years - | Harvard School of Public Health (HSPH) | |
| The Prevalence of Oral HPV Infection and Oral Lesions in People Living With HIV | NCT06205511 | Human Immunodef... Human Papilloma... | Oral HPV Sample | 18 Years - | Vivent Health | |
| Impact of a New Plant-based High-energy Oral Nutritional Supplement on Nutritional Outcomes in Malnourished Patients | NCT06055543 | Malnutrition Cancer Inflammatory Bo... Chronic Obstruc... Hiv | Fortimel | 18 Years - | Danone Specialized Nutrition | |
| Pilot Study of Liposomal Doxorubicin Combined With Bevacizumab Followed by Bevacizumab Monotherapy in Adults With Advanced Kaposi s Sarcoma | NCT00923936 | Sarcoma, Kaposi | Liposomal Doxor... Bevacizumab | 18 Years - 99 Years | National Institutes of Health Clinical Center (CC) | |
| Integrated Discovery of New Immuno-Molecular Actionable Biomarkers for Tumors With Immune-suppressed Environment | NCT03706625 | Non Hodgkin Lym... Non Small Cell ... Glioma | 18 Years - | Assistance Publique - Hôpitaux de Paris | ||
| ACCESS: Accelerating Cervical Cancer Elimination Through the Integration of Screen-and-treat Services | NCT06128304 | HIV Cervical Cancer | Core Implementa... Core+ Enhanced ... | 25 Years - 65 Years | University of California, San Diego | |
| Anal Dysplasia Study of Men Who Have Sex With Men Living With HIV | NCT01663558 | Anal Dysplasia Human Papilloma... HIV | imiquimod ablative | 18 Years - | United States Naval Medical Center, San Diego | |
| Estimating the Global Need for Palliative Care for Children | NCT02553148 | Cancer Congenital Anom... Cardiovascular ... HIV | Need for childr... | - 19 Years | International Children's Palliative Care Network | |
| Stem Cell (Modified Bone Marrow) Transplantation in HIV-Infected Patients With Blood Cancer | NCT00005785 | Hematologic Neo... HIV Infection | GCSF Mobilized ... | - | National Institutes of Health Clinical Center (CC) | |
| Natural History Study of Kaposi Sarcoma | NCT06375122 | Kaposi Sarcoma HIV | 18 Years - 120 Years | National Institutes of Health Clinical Center (CC) | ||
| Acquired Epidermodysplasia Verruciformis (EV) Syndrome in HIV-infected Pediatric Patients | NCT01289171 | Flat Warts HIV | Glycolic acid | 7 Years - | University of Pennsylvania | |
| Rituximab Plus CHOP Chemotherapy for Diffuse Large B-cell Lymphoma | NCT02660710 | Diffuse Large B... HIV | R-CHOP | 18 Years - 60 Years | UNC Lineberger Comprehensive Cancer Center | |
| High-dose Chemotherapy With Transplantation of Gene-modified Haematopoietic Stem Cells for HIV-positive Patients With Malignant Diseases Indicating an HSCT | NCT00858793 | AIDS-related Ly... HIV Infections | PBSC-M87o, Gene... | 18 Years - 65 Years | Universitätsklinikum Hamburg-Eppendorf | |
| A Pilot Study to Examine the Feasibility and Effect of Tumor Necrosis Factor (TNF) Inhibition on HIV Disease | NCT00205231 | HIV Infections | etanercept | 18 Years - | University of Wisconsin, Madison | |
| Prevalence and Longitudinal Follow-up of Anal Lesions, HPV Infection and Associated Sexually Transmitted Infections Among Men Who Have Sex With Men in Togo. | NCT04910438 | Papillomavirus ... HIV Infections | STIs screening ... | 18 Years - | ANRS, Emerging Infectious Diseases | |
| HPV Infection and Cervical Lesions in HIV Infected Women in Thailand: A Prospective Study | NCT01792973 | Cervical Cancer | 18 Years - | Institut de Recherche pour le Developpement | ||
| Allogeneic Transplant in HIV Patients (BMT CTN 0903) | NCT01410344 | Leukemia Lymphoma HIV | Fludarabine and... Fludarabine and... Busulfan and Fl... Cyclophosphamid... | 15 Years - | Medical College of Wisconsin | |
| Genetic Factors and Interrelationships for Cancer Risk-Related Behaviors and Complex Traits | NCT00001500 | Acquired Immuno... Alcoholism HIV Infection Neoplasm Smoking | - | National Institutes of Health Clinical Center (CC) | ||
| Northwest Therapies Trauma Psilocybin Study Compassionate Use Study | NCT05042466 | Trauma, Nervous... | Trauma | 21 Years - 99 Years | NWTraumatherapies | |
| ERADICATING CERVICAL CANCER IN KENYA | NCT04774887 | Human Papilloma... HIV Infections | HPV vaccine, Me... | 9 Years - 60 Years | Indiana University | |
| Randomized, Double Blind Trial of the Quadrivalent HPV Vaccine to Improve Responses to LEEP Treatment of Cervical HSIL | NCT01928225 | Cervical High G... | Human Papilloma... | 18 Years - | University of Witwatersrand, South Africa | |
| Durvalumab in Solid Tumors | NCT03094286 | HIV Cancer | Durvalumab | 18 Years - | Spanish Lung Cancer Group | |
| ERADICATING CERVICAL CANCER IN KENYA | NCT04774887 | Human Papilloma... HIV Infections | HPV vaccine, Me... | 9 Years - 60 Years | Indiana University | |
| Autologous Transplant in HIV Patients (BMT CTN 0803) | NCT01141712 | Lymphoma HIV | Autologous tran... BCNU Etoposide Cytarabine Melphalan | 15 Years - | Medical College of Wisconsin | |
| ACCESS: Accelerating Cervical Cancer Elimination Through the Integration of Screen-and-treat Services | NCT06128304 | HIV Cervical Cancer | Core Implementa... Core+ Enhanced ... | 25 Years - 65 Years | University of California, San Diego | |
| Natural History Study of Kaposi Sarcoma | NCT06375122 | Kaposi Sarcoma HIV | 18 Years - 120 Years | National Institutes of Health Clinical Center (CC) | ||
| PROLIFICA - West African Treatment Cohort for Hepatitis B | NCT02129829 | Hepatitis B, Ch... Hepatocellular ... | Tenofovir disop... | 18 Years - | Imperial College London | |
| Prevalence and Longitudinal Follow-up of Anal Lesions, HPV Infection and Associated Sexually Transmitted Infections Among Men Who Have Sex With Men in Togo. | NCT04910438 | Papillomavirus ... HIV Infections | STIs screening ... | 18 Years - | ANRS, Emerging Infectious Diseases | |
| Anal HPV Infection and Abnormal Cytology in HIV-infected Women | NCT00933140 | Cervical Cancer... HIV Infections | 18 Years - 64 Years | Boston Medical Center | ||
| Intralesional Bevacizumab for Treating AIDS-associated Kaposi´s Sarcoma of the Larynx, Pharynx and Oral Cavity | NCT01296815 | Kaposi´s Sarcom... | Bevacizumab | 18 Years - 60 Years | Centro de Investigación en. Enfermedades Infecciosas, Mexico | |
| Study of Safety, Tolerability and Immunogenicity of Gardasil®9 in Immunocompromised Patients | NCT03525210 | Human Papilloma... Hiv Organ Transplan... | 9-valent HPV va... | 18 Years - 55 Years | Universitaire Ziekenhuizen KU Leuven | |
| Investigating Chemotherapy Treatments, Response and Subsets of HIV-associated Kaposi Sarcoma in Malawi | NCT03160183 | Kaposi Sarcoma HIV | 18 Years - 99 Years | UNC Lineberger Comprehensive Cancer Center | ||
| HPV Infection, Sexually Transmitted Infections and Anal Dysplasia in the Transgender Population | NCT05981807 | Human Papilloma... Human Immunodef... Sexually Transm... | 18 Years - | ANRS, Emerging Infectious Diseases | ||
| Development of Serologic Assays for Human Herpes Virus-8 | NCT00395278 | Kaposi Sarcoma HIV Infection | 18 Years - 99 Years | National Institutes of Health Clinical Center (CC) | ||
| The Effect of HPV Vaccination on Recurrence Rates in HIV Patients With Condylomata | NCT00941889 | HIV Positive Anal Condylomat... Anal Warts HIV Infections | Saline Quadrivalent Hu... | 18 Years - | Washington University School of Medicine | |
| The Effect of HPV Vaccination on Recurrence Rates in HIV Patients With Condylomata | NCT00941889 | HIV Positive Anal Condylomat... Anal Warts HIV Infections | Saline Quadrivalent Hu... | 18 Years - | Washington University School of Medicine | |
| Study of the Humoral Response to SARS-CoV-2 Variants and of the Cellular Response After Vaccination Against COVID-19 in Immunocompromised People | NCT04844489 | Autoimmune or A... HIV Multiple Sclero... Solid Tumors or... Solid Organ Tra... | Blood samples f... | 18 Years - | Assistance Publique - Hôpitaux de Paris | |
| Virotherapy and Natural History Study of KHSV-Associated Multricentric Castleman s Disease With Correlates of Disease Activity | NCT00092222 | Lymphoprolifera... HHV-8 Malignancy HIV | Etoposide Interferon-alph... Rituximab Zidovudine Liposomal Doxor... Bortezomib Valganciclovir Doxorubicin Vincristine Cyclophosphamid... Filgrastim (G-C... Prednisone Sirolimus Observation Onl... | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| Short Term Intensified Chemo-immunotherapy in HIV-positive Patients With Burkitt Lymphoma | NCT01516593 | HIV Burkitt's Lymph... | Induction Phase Consolidation P... Intensification... BEAM conditioni... Consolidation r... | 18 Years - 60 Years | IRCCS San Raffaele | |
| LINFOTARGAM: Treatment With Chemotherapy Plus Rituximab and Highly Active Antiretroviral Therapy in Patients With Diffuse Large B Cell Lymphoma and Infection With the Human Immunodeficiency Virus (HIV) | NCT00466258 | HIV Infections Diffuse Large B... | R-CHOP Highly active a... Central nervous... Prophylaxis of ... | 18 Years - 70 Years | PETHEMA Foundation | |
| Identifying and Addressing Barriers to Retention in the Cervical Cancer Treatment Cascade Among Women With HIV in South Africa: Part 2 | NCT06182241 | Cervical Cancer Hiv | Retention in ce... | 18 Years - | Boston University Charles River Campus | |
| Impact of a New Plant-based High-energy Oral Nutritional Supplement on Nutritional Outcomes in Malnourished Patients | NCT06055543 | Malnutrition Cancer Inflammatory Bo... Chronic Obstruc... Hiv | Fortimel | 18 Years - | Danone Specialized Nutrition | |
| HPV (Human Papilloma Virus) Vaccination After Treatment of Anal Intraepithelial Neoplasia (AIN) | NCT02087384 | AIN HIV | Gardasil Placebo | 18 Years - | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | |
| Integrated Discovery of New Immuno-Molecular Actionable Biomarkers for Tumors With Immune-suppressed Environment | NCT03706625 | Non Hodgkin Lym... Non Small Cell ... Glioma | 18 Years - | Assistance Publique - Hôpitaux de Paris | ||
| Pomalidomide in Combination With Liposomal Doxorubicin in People With Advanced or Refractory Kaposi Sarcoma | NCT02659930 | Kaposi Sarcoma | liposomal doxor... pomalidomide | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| Effects of Maraviroc (MVC) on HIV-related Kaposi's Sarcoma (KS) | NCT01276236 | Kaposi's Sarcom... | Maraviroc | 18 Years - | University of California, San Francisco | |
| Trial of Allogeneic Reduced-Intensity, HLA-Haploidentical Bone Marrow Transplantation Followed by Graft-versus-Host-Disease (GVHD) Prophylaxis With Cyclophosphamide, Bortezomib and Maraviroc for Hematologic Malignancies in People Living With HIV | NCT05470491 | HIV Hematologic Mal... | RIC GVHD prophylaxi... allo HCT Plerixafor Maraviroc | 12 Years - 120 Years | National Institutes of Health Clinical Center (CC) | |
| Topical Curcumin for HPV Related Cervical Disease | NCT04266275 | Neoplasm Cervix | Curcumin C3 Com... Placebo | 21 Years - | Emory University | |
| Randomized, Double Blind Trial of the Quadrivalent HPV Vaccine to Improve Responses to LEEP Treatment of Cervical HSIL | NCT01928225 | Cervical High G... | Human Papilloma... | 18 Years - | University of Witwatersrand, South Africa | |
| Study Evaluating SARS-CoV-2 (COVID-19) Humoral Response After BNT162b2 Vaccine in Immunocompromised Adults Compared to Healthy Adults | NCT04952766 | Kidney Transpla... Myeloma Cancer Hematologic Mal... Multiple Sclero... Hypergammaglobu... Malignant Tumor Hiv Diabetes Type 2 | Biological samp... | 18 Years - | Centre Hospitalier Régional d'Orléans | |
| A Multilevel Intervention to Improve Timely Cancer Detection and Treatment Initiation | NCT04141449 | Neoplasms Hiv Cervical Cancer Breast Cancer HNSCC Vulvar Cancer Anal Cancer Cancer Suspect | Potlako interve... Enhanced care | 30 Years - | Brigham and Women's Hospital | |
| Effects of Potent Antiretroviral Therapy on Kaposi s Sarcoma | NCT00006171 | HIV Seropositiv... Kaposi's Sarcom... HIV Infections | 13 Years - | National Institutes of Health Clinical Center (CC) | ||
| Visual Inspection With Acetic Acid Compared to Lugol's Iodine in HIV-infected Women | NCT02237326 | Cervical Intrae... Cervical Cancer HIV | Visual Inspecti... Visual Inspecti... | 23 Years - 59 Years | University of California, San Francisco | |
| Acquired Epidermodysplasia Verruciformis (EV) Syndrome in HIV-infected Pediatric Patients | NCT01289171 | Flat Warts HIV | Glycolic acid | 7 Years - | University of Pennsylvania | |
| HIV/AIDS Kaposis Sarcoma: Comparison of Response to HAART vs HAART Plus CXT | NCT00380770 | HIV AIDS Kaposi's Sarcom... Human Herpesvir... | Generic HAART T... Generic HAART T... | 18 Years - | University of KwaZulu | |
| PROLIFICA - West African Treatment Cohort for Hepatitis B | NCT02129829 | Hepatitis B, Ch... Hepatocellular ... | Tenofovir disop... | 18 Years - | Imperial College London | |
| Allogeneic Transplant in HIV Patients (BMT CTN 0903) | NCT01410344 | Leukemia Lymphoma HIV | Fludarabine and... Fludarabine and... Busulfan and Fl... Cyclophosphamid... | 15 Years - | Medical College of Wisconsin | |
| Daratumumab for Relapsed/Refractory Primary Effusion Lymphoma | NCT05907759 | Lymphoma, Prima... | Daratumumab SC | 18 Years - 120 Years | National Institutes of Health Clinical Center (CC) | |
| High Dose Therapy and Peripheral Blood Stem Cell Transplantation in HIV Related Non Hodgkin Lymphoma (NHL) at High Risk | NCT01045889 | HIV-related Lym... HIV Infections | Rituximab and C... | 18 Years - 60 Years | Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia | |
| Prevalence and Longitudinal Follow-up of Anal Lesions, HPV Infection and Associated Sexually Transmitted Infections Among Men Who Have Sex With Men in Togo. | NCT04910438 | Papillomavirus ... HIV Infections | STIs screening ... | 18 Years - | ANRS, Emerging Infectious Diseases | |
| Study of the Humoral Response to SARS-CoV-2 Variants and of the Cellular Response After Vaccination Against COVID-19 in Immunocompromised People | NCT04844489 | Autoimmune or A... HIV Multiple Sclero... Solid Tumors or... Solid Organ Tra... | Blood samples f... | 18 Years - | Assistance Publique - Hôpitaux de Paris | |
| The MARVIN Chatbots to Provide Information for Different Health Conditions | NCT05789901 | HIV Infections Breast Cancer Pediatric Emerg... | MARVIN MARVIN-Pharma MARVINA MARVIN-CHAMP | 14 Years - | McGill University Health Centre/Research Institute of the McGill University Health Centre | |
| Finding Barriers and Designing Solutions to Promote Women s Cancer Screening in South Africa | NCT05414097 | Cervical Cancer | Semi-structured... semi-structured... In-depth key st... Discrete Choice... Development and... | 18 Years - | UNC Lineberger Comprehensive Cancer Center | |
| Potlako: A Programmatic Intervention to Improve Access to Timely Oncology Care | NCT02752061 | Neoplasms HIV Healthcare Disp... | Potlako interve... | 18 Years - | Harvard School of Public Health (HSPH) | |
| Pilot Study to Determine the Safety and Efficacy of Gardasil Against the Human Papilloma Virus (HPV) in HIV-infected Men | NCT00666107 | Anal Cancer HIV Infections | Gardasil | 18 Years - | Southern California Institute for Research and Education | |
| High-dose Chemotherapy With Transplantation of Gene-modified Haematopoietic Stem Cells for HIV-positive Patients With Malignant Diseases Indicating an HSCT | NCT00858793 | AIDS-related Ly... HIV Infections | PBSC-M87o, Gene... | 18 Years - 65 Years | Universitätsklinikum Hamburg-Eppendorf | |
| Natural History Study of Kaposi Sarcoma | NCT06375122 | Kaposi Sarcoma HIV | 18 Years - 120 Years | National Institutes of Health Clinical Center (CC) | ||
| The Second Multicenter Hemophilia Cohort Study | NCT00341705 | Liver Decompens... Hepatocellular ... Non-Hodgkin Lym... | 13 Years - | National Institutes of Health Clinical Center (CC) | ||
| Evolution of Cellular and Viral Resistance in HIV-infected Patients With Lymphoma | NCT01330342 | HIV Lymphoma | - | St Stephens Aids Trust | ||
| HIV/AIDS Kaposis Sarcoma: Comparison of Response to HAART vs HAART Plus CXT | NCT00380770 | HIV AIDS Kaposi's Sarcom... Human Herpesvir... | Generic HAART T... Generic HAART T... | 18 Years - | University of KwaZulu | |
| Effects of Maraviroc (MVC) on HIV-related Kaposi's Sarcoma (KS) | NCT01276236 | Kaposi's Sarcom... | Maraviroc | 18 Years - | University of California, San Francisco | |
| Eligibility Screening for the NIH Intramural Research Program Clinical Protocols | NCT00026754 | Breast Cancer Prostate Cancer Lung Cancer Sarcoma Melanoma | 1 Month - | National Institutes of Health Clinical Center (CC) | ||
| Short Term Intensified Chemo-immunotherapy in HIV-positive Patients With Burkitt Lymphoma | NCT01516593 | HIV Burkitt's Lymph... | Induction Phase Consolidation P... Intensification... BEAM conditioni... Consolidation r... | 18 Years - 60 Years | IRCCS San Raffaele | |
| ACCESS: Accelerating Cervical Cancer Elimination Through the Integration of Screen-and-treat Services | NCT06128304 | HIV Cervical Cancer | Core Implementa... Core+ Enhanced ... | 25 Years - 65 Years | University of California, San Diego | |
| Anal Dysplasia Study of Men Who Have Sex With Men Living With HIV | NCT01663558 | Anal Dysplasia Human Papilloma... HIV | imiquimod ablative | 18 Years - | United States Naval Medical Center, San Diego | |
| Non Invasive Oral Cancer Screening Among HIV Infected Individuals | NCT02823847 | Malignant Neopl... Human Immunodef... | Screening Inter... Carbon Monoxide... Self-Help Mater... Visual Oral Scr... Direct Fluoresc... Oral Biopsy | 18 Years - | M.D. Anderson Cancer Center | |
| Anal HPV Infection and Abnormal Cytology in HIV-infected Women | NCT00933140 | Cervical Cancer... HIV Infections | 18 Years - 64 Years | Boston Medical Center | ||
| Anal HPV Infection and Abnormal Cytology in HIV-infected Women | NCT00933140 | Cervical Cancer... HIV Infections | 18 Years - 64 Years | Boston Medical Center |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
